Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexinidazole in Children with HAT
NCT02184689Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Fexinidazole in human African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Started May 2014; status: completed.
02
Drugs
Fexinidazole
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT02184689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184689.